Assignee
SYNTHETIC BIOLOGICS INC
US·25 granted patents·11 pending applications·38 citations·filing 2015–2022
Top patents by PatentIndex Score
36 records- 0195US11236319B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2020·Granted Feb 1, 2022·2 cites·12 claims
- 0293US10767171B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2020·Granted Sep 8, 2020·2 cites·10 claims
- 0391US9744221B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2015·Granted Aug 29, 2017·3 cites·12 claims
- 0487US10987410B2Alkaline phosphatase formulationsSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Apr 27, 2021·3 cites·6 claims
- 0587US10584326B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2019·Granted Mar 10, 2020·2 cites·18 claims
- 0687US10336995B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2018·Granted Jul 2, 2019·2 cites·12 claims
- 0786US10087433B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2018·Granted Oct 2, 2018·2 cites·18 claims
- 0886US10011824B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2017·Granted Jul 3, 2018·2 cites·31 claims
- 0986US9783797B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2017·Granted Oct 10, 2017·2 cites·32 claims
- 1086US9464280B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Oct 11, 2016·2 cites·25 claims
- 1186US9404103B1Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Aug 2, 2016·2 cites·29 claims
- 1285US10548955B2Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Feb 4, 2020·3 cites·14 claims
- 1385US9695409B2Beta-lactamases with improved properties for therapySYNTHETIC BIOLOGICS INC·Filed 2016·Granted Jul 4, 2017·2 cites·35 claims
- 1484US10253306B2Modified beta-lactamases and methods and uses related theretoSYNTHETIC BIOLOGICS INC·Filed 2017·Granted Apr 9, 2019·2 cites·13 claims
- 1583US11253577B2Safe and effective beta-lactamase dosing for microbiome protectionSYNTHETIC BIOLOGICS INC·Filed 2020·Granted Feb 22, 2022·2 cites·18 claims
- 1683US10046035B2Methods and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2017·Granted Aug 14, 2018·2 cites·12 claims
- 1783US10041056B2Modified beta-lactamases and methods and uses related theretoSYNTHETIC BIOLOGICS INC·Filed 2017·Granted Aug 7, 2018·2 cites·10 claims
- 1880US2022090044A1Modified beta-lactamases and methods and uses related theretoSYNTHETIC BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 1977US9587234B2Modified beta-lactamases and methods and uses related theretoSYNTHETIC BIOLOGICS INC·Filed 2016·Granted Mar 7, 2017·1 cites·12 claims
- 2074US2022000991A1Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGICS INC·Filed 2021·Application pending·0 cites
- 2173US10792346B2Method and compositions for inhibiting or preventing adverse effects of oral antibioticsSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Oct 6, 2020·0 cites·16 claims
- 2272US11542510B2E. coli-based production of beta-lactamaseSYNTHETIC BIOLOGICS INC·Filed 2021·Granted Jan 3, 2023·0 cites·14 claims
- 2370US10828260B2Beta-lactamase formulations and uses thereofSYNTHETIC BIOLOGICS INC·Filed 2018·Granted Nov 10, 2020·0 cites·12 claims
- 2469US2022241383A1Alkaline phosphatase agents for treatment of neurodevelopmental disordersSYNTHETIC BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 2563US9765320B2Modified beta-lactamases and methods and uses related theretoSYNTHETIC BIOLOGICS INC·Filed 2016·Granted Sep 19, 2017·0 cites·14 claims
- 2661US10105322B2Beta-lactamase formulations and uses thereofSYNTHETIC BIOLOGICS INC·Filed 2015·Granted Oct 23, 2018·0 cites·14 claims
- 2758US2019275120A1Methods and compositions for attenuating antibiotic resistanceSYNTHETIC BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2856US10709773B2Safe and effective beta-lactamase dosing for microbiome protectionSYNTHETIC BIOLOGICS INC·Filed 2016·Granted Jul 14, 2020·0 cites·8 claims
- 2954US2016250304A1Carbapenemases for use with antibiotics for the protection of the intestinal microbiomeSYNTHETIC BIOLOGICS INC·Filed 2016·Application pending·0 cites
- 3052US11034966B2E. coli-based production of beta-lactamaseSYNTHETIC BIOLOGICS INC·Filed 2015·Granted Jun 15, 2021·0 cites·8 claims
- 3151US2022218800A1Beta-lactamase compositions for treatment of graft versus host diseaseSYNTHETIC BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 3247US2022257726A1Intestinal alkaline phosphatase-based treatments of metabolic disordersSYNTHETIC BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 3344US2020108130A1Beta-lactamase formulationsSYNTHETIC BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 3444US2022323367A1Alkaline phosphatase formulations and uses thereofSYNTHETIC BIOLOGICS INC·Filed 2020·Application pending·0 cites
- 3540US2021189358A1Methods of making alkaline phosphatase agentsSYNTHETIC BIOLOGICS INC·Filed 2019·Application pending·0 cites
- 3640US2019277833A1Anti-methanogenic compositionsSYNTHETIC BIOLOGICS INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SYNTHETIC BIOLOGICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →